pharma_company
stringclasses 562
values | brand_name_en
stringlengths 19
232
| generic_name_en
stringlengths 21
250
| substance_name_en
stringclasses 983
values | atc_code_raw
stringclasses 778
values | anatomical_desc
stringclasses 14
values | therapeutic_desc
stringclasses 82
values | pharmacological_desc
stringclasses 181
values | subpharmacological_desc
stringclasses 365
values | chemical_desc
stringclasses 636
values |
---|---|---|---|---|---|---|---|---|---|
Sana Med Pharmaceutical | VITAMIN B1-SANA MED TABLET ORAL 300 mg | VITAMIN B1 (THIAMINE) TABLET ORAL 300 mg | VITAMIN B1 (THIAMINE) | A11DA01 | ALIMENTARY TRACT AND METABOLISM | VITAMINS | VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 | Vitamin B1, plain | thiamine (vit B1) |
Sobhandarou | CITALOPRAM TABLET ORAL 20 mg | CITALOPRAM TABLET ORAL 20 mg | CITALOPRAM | N06AB04 | NERVOUS SYSTEM | PSYCHOANALEPTICS | ANTIDEPRESSANTS | Selective serotonin reuptake inhibitors | citalopram |
Toliddaru Pharma. Co. | METOPROLOL TARTRATE TABLET ORAL 50 mg | METOPROLOL TARTRATE TABLET ORAL 50 mg | METOPROLOL TARTRATE | C07AB02 | CARDIOVASCULAR SYSTEM | BETA BLOCKING AGENTS | BETA BLOCKING AGENTS | Beta blocking agents, selective | metoprolol |
Loghman Pharmaceutical & Hygienic (public) | ACETAMINOPHEN/CODEINE TABLET ORAL 300 mg/20 mg | ACETAMINOPHEN / CODEINE PHOSPHATE TABLET ORAL 300 mg/20 mg | ACETAMINOPHEN / CODEINE PHOSPHATE | N02BE71 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol, combinations with psycholeptics |
Teb-mofid-nikan | GABAPENTIN CAPSULE ORAL 100 mg | GABAPENTIN CAPSULE ORAL 100 mg | GABAPENTIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Aburaihan Pharmaceutical Co | PSORIABET OINTMENT TOPICAL 0.005 %/0.064 % 30 g | CALCIPOTRIOL / BETAMETHASONE DIPROPIONATE OINTMENT TOPICAL 0.005 %/0.064 % 30 g | CALCIPOTRIOL / BETAMETHASONE DIPROPIONATE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Sepidaj Pharmaceutical Company | CLINDAMYCIN-SEPIDAJ SOLUTION TOPICAL 10 mg/1mL 60 mL | CLINDAMYCIN (AS PHOSPHATE) SOLUTION TOPICAL 10 mg/1mL 60 mL | CLINDAMYCIN (AS PHOSPHATE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Hakim Pharmaceutical Co. | KETOTIFEN-HAKIM SYRUP ORAL 1 mg/5mL 120 mL | KETOTIFEN SYRUP ORAL 1 mg/5mL 120 mL | KETOTIFEN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Toliddaru Pharma. Co. | SERTRALINE TABLET ORAL 50 mg | SERTRALINE (AS HYDROCHLORIDE) TABLET ORAL 50 mg | SERTRALINE (AS HYDROCHLORIDE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Behvazan Pharmaceutical | DALAZAN SOLUTION TOPICAL 10 mg/1mL 60 mL | CLINDAMYCIN (AS PHOSPHATE) SOLUTION TOPICAL 10 mg/1mL 60 mL | CLINDAMYCIN (AS PHOSPHATE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Aburaihan Pharmaceutical Co | VENUSTATE CAPSULE ORAL 120 mg | ORLISTAT CAPSULE ORAL 120 mg | ORLISTAT | A08AB01 | ALIMENTARY TRACT AND METABOLISM | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | Peripherally acting antiobesity products | orlistat |
Sepidaj Pharmaceutical Company | MINOXIDIL-SEPIDAJ SOLUTION TOPICAL 50 mg/1mL 60 mL | MINOXIDIL SOLUTION TOPICAL 50 mg/1mL 60 mL | MINOXIDIL | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Toliddaru Pharma. Co. | BISACODYL TABLET, DELAYED RELEASE ORAL 5 mg | BISACODYL TABLET, DELAYED RELEASE ORAL 5 mg | BISACODYL | A06AB02 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR CONSTIPATION | DRUGS FOR CONSTIPATION | Contact laxatives | bisacodyl |
Ronak Pharmaceutical | COLISTIMETHATE INJECTION, POWDER, FOR SOLUTION PARENTERAL 4500000 [iU] [iU] | COLISTIMETHATE SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 4500000 [iU] | COLISTIMETHATE SODIUM | J01XB01 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | OTHER ANTIBACTERIALS | Polymyxins | colistin |
Aburaihan Pharmaceutical Co | TESTOSTERONE ENANTHATE INJECTION PARENTERAL 100 mg/1mL mL | TESTOSTERONE ENANTHATE INJECTION PARENTERAL 100 mg/1mL | TESTOSTERONE ENANTHATE | G03BA03 | GENITO URINARY SYSTEM AND SEX HORMONES | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | ANDROGENS | 3-oxoandrosten (4) derivatives | testosterone |
Amin Pharmaceutical Co. | LEVOFECT TABLET ORAL 750 mg | LEVOFLOXACIN TABLET ORAL 750 mg | LEVOFLOXACIN | J01MA12 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | QUINOLONE ANTIBACTERIALS | Fluoroquinolones | levofloxacin |
Tehran Chemie Pharmaceutical Co. | DEMITRON TABLET ORAL 4 mg | ONDANSETRON TABLET ORAL 4 mg | ONDANSETRON | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pfizer | DEPO-MEDROL INJECTION, SUSPENSION PARENTERAL 40 mg/1mL mg | METHYLPREDNISOLONE ACETATE INJECTION, SUSPENSION PARENTERAL 40 mg/1mL | METHYLPREDNISOLONE ACETATE | H02AB04 | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | CORTICOSTEROIDS FOR SYSTEMIC USE | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | Glucocorticoids | methylprednisolone |
Raha Pharmaceutical Isfahan Company | IBUPROFEN TABLET ORAL 400 mg | IBUPROFEN TABLET ORAL 400 mg | IBUPROFEN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Shahre Daru | BIQUEL TABLET ORAL 25 mg | QUETIAPINE FUMARATE TABLET ORAL 25 mg | QUETIAPINE FUMARATE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Exir Pharmaceutical Company | ZIMEXIR CAPSULE ORAL 500 mg | AZITHROMYCIN CAPSULE ORAL 500 mg | AZITHROMYCIN | J01FA10 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | Macrolides | azithromycin |
Toliddaru Pharma. Co. | AZITHROMYCIN CAPSULE ORAL 500 mg | AZITHROMYCIN CAPSULE ORAL 500 mg | AZITHROMYCIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Aburaihan Pharmaceutical Co | METHYLPREDNISOLONE ACETATE INJECTION, SUSPENSION PARENTERAL 40 mg/1mL mL | METHYLPREDNISOLONE ACETATE INJECTION, SUSPENSION PARENTERAL 40 mg/1mL | METHYLPREDNISOLONE ACETATE | H02AB04 | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | CORTICOSTEROIDS FOR SYSTEMIC USE | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | Glucocorticoids | methylprednisolone |
Avicenna Laboratories Inc. | FLUCONAZOLE TABLET ORAL 150 mg | FLUCONAZOLE TABLET ORAL 150 mg | FLUCONAZOLE | J02AC01 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIMYCOTICS FOR SYSTEMIC USE | ANTIMYCOTICS FOR SYSTEMIC USE | Triazole derivatives | fluconazole |
Aburaihan Pharmaceutical Co | PSORIAMENT OINTMENT TOPICAL 50 ug/1g 30 g | CALCIPOTRIOL OINTMENT TOPICAL 50 ug/1g 30 g | CALCIPOTRIOL | D05AX02 | DERMATOLOGICALS | ANTIPSORIATICS | ANTIPSORIATICS FOR TOPICAL USE | Other antipsoriatics for topical use | calcipotriol |
Shafa Pharmaceutical & Hygienic Mfg.co. | SUMATRIPTAN TABLET ORAL 50 mg | SUMATRIPTAN (AS SUCCINATE) TABLET ORAL 50 mg | SUMATRIPTAN (AS SUCCINATE) | N02CC01 | NERVOUS SYSTEM | ANALGESICS | ANTIMIGRAINE PREPARATIONS | Selective serotonin (5HT1) agonists | sumatriptan |
Raha Pharmaceutical Isfahan Company | PSEUPHAN SYRUP ORAL 15 mg/30 mg/5mL mL | DEXTROMETHORPHAN / PSEUDOEPHEDRINE SYRUP ORAL 15 mg/30 mg/5mL | DEXTROMETHORPHAN / PSEUDOEPHEDRINE | R05DA20 | RESPIRATORY SYSTEM | COUGH AND COLD PREPARATIONS | COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS | Opium alkaloids and derivatives | combinations |
Soha Pharmaceutical Co. | METFORBET TABLET ORAL 1000 mg | METFORMIN HYDROCHLORIDE TABLET ORAL 1000 mg | METFORMIN HYDROCHLORIDE | A10BA02 | ALIMENTARY TRACT AND METABOLISM | DRUGS USED IN DIABETES | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | Biguanides | metformin |
Emad Darman Pars | ELOCOMAD CREAM TOPICAL 0.1 % 30 g | MOMETASONE FUROATE CREAM TOPICAL 0.1 % 30 g | MOMETASONE FUROATE | D07AC13 | DERMATOLOGICALS | CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | CORTICOSTEROIDS, PLAIN | Corticosteroids, potent (group III) | mometasone |
Toliddaru Pharma. Co. | CLINDAMYCIN CAPSULE ORAL 150 mg | CLINDAMYCIN (AS HYDROCHLORIDE) CAPSULE ORAL 150 mg | CLINDAMYCIN (AS HYDROCHLORIDE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Iran Daru | TETRACYCLINE OINTMENT TOPICAL 3 % 15 g | TETRACYCLINE HYDROCHLORIDE OINTMENT TOPICAL 3 % 15 g | TETRACYCLINE HYDROCHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Iran Daru | BIOTIN TABLET ORAL 5 mg | BIOTIN TABLET ORAL 5 mg | BIOTIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Sobhandarou | ABILIZOL TABLET ORAL 15 mg | ARIPIPRAZOLE TABLET ORAL 15 mg | ARIPIPRAZOLE | N05AX12 | NERVOUS SYSTEM | PSYCHOLEPTICS | ANTIPSYCHOTICS | Other antipsychotics | aripiprazole |
Shahre Daru | THEOMEX CAPSULE, COATED, EXTENDED RELEASE ORAL 200 mg | THEOPHYLLINE CAPSULE, COATED, EXTENDED RELEASE ORAL 200 mg | THEOPHYLLINE | R03DA04 | RESPIRATORY SYSTEM | DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | Xanthines | theophylline |
Shahid Ghazi Pharmaceutical Co. | DEXTROSE /SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 5 %/0.45 % 500 mL | DEXTROSE / SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 5 %/0.45 % 500 mL | DEXTROSE / SODIUM CHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pharmachemie | PHARMELA-P CREAM TOPICAL 2.5 %/2.5 % 30 g | LIDOCAINE / PRILOCAINE CREAM TOPICAL 2.5 %/2.5 % 30 g | LIDOCAINE / PRILOCAINE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Tehran Darou Pharmaceutical Co. | LITMON TABLET ORAL 300 mg | LITHIUM CARBONATE TABLET ORAL 300 mg | LITHIUM CARBONATE | N05AN01 | NERVOUS SYSTEM | PSYCHOLEPTICS | ANTIPSYCHOTICS | Lithium | lithium |
Alhavi | DEXTROMETHORPHAN-ALHAVI SYRUP ORAL 15 mg/5mL 60 mL | DEXTROMETHORPHAN HYDROBROMIDE SYRUP ORAL 15 mg/5mL 60 mL | DEXTROMETHORPHAN HYDROBROMIDE | R05DA09 | RESPIRATORY SYSTEM | COUGH AND COLD PREPARATIONS | COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS | Opium alkaloids and derivatives | dextromethorphan |
Pharmachemie | ACETAMINOPHEN SUPPOSITORY RECTAL 325 mg g | ACETAMINOPHEN SUPPOSITORY RECTAL 325 mg | ACETAMINOPHEN | N02BE01 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol |
Caspian Tamin Co. | OXYTIP INJECTION PARENTERAL 10 U/1mL mL | OXYTOCIN INJECTION PARENTERAL 10 U/1mL | OXYTOCIN | H01BB02 | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES | POSTERIOR PITUITARY LOBE HORMONES | Oxytocin and analogues | oxytocin |
Caspian Tamin Co. | IPOZINC OINTMENT TOPICAL 25 % 30 g | ZINC OXIDE OINTMENT TOPICAL 25 % 30 g | ZINC OXIDE | D02AB | DERMATOLOGICALS | EMOLLIENTS AND PROTECTIVES | EMOLLIENTS AND PROTECTIVES | Zinc products | null |
Alborzdarou | ADIGEL SUSPENSION ORAL 225 mg/200 mg/5 mL 240 mL | ALUMINIUM HYDROXIDE / MAGNESIUM HYDROXIDE SUSPENSION ORAL 225 mg/200 mg/5 mL 240 mL | ALUMINIUM HYDROXIDE / MAGNESIUM HYDROXIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Raha Pharmaceutical Isfahan Company | OXYNOSE SPRAY NASAL 0.05 % 15 mL | OXYMETAZOLINE HYDROCHLORIDE SPRAY NASAL 0.05 % 15 mL | OXYMETAZOLINE HYDROCHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Sajad Daru Shargh | BISACODYL TABLET, DELAYED RELEASE ORAL 5 mg | BISACODYL TABLET, DELAYED RELEASE ORAL 5 mg | BISACODYL | A06AB02 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR CONSTIPATION | DRUGS FOR CONSTIPATION | Contact laxatives | bisacodyl |
Zahravi Pharmaceutical | ACETAPEARL CAPSULE, GELATIN COATED ORAL 500 mg | ACETAMINOPHEN CAPSULE, GELATIN COATED ORAL 500 mg | ACETAMINOPHEN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Sobhandarou | HALOPERIDOL SOLUTION ORAL 2 mg/1mL 15 mL | HALOPERIDOL (AS LACTATE) SOLUTION ORAL 2 mg/1mL 15 mL | HALOPERIDOL (AS LACTATE) | N05AD01 | NERVOUS SYSTEM | PSYCHOLEPTICS | ANTIPSYCHOTICS | Butyrophenone derivatives | haloperidol |
NEAL PHARMED | PANTONILE CAPSULE, DELAYED RELEASE ORAL 40 mg | PANTOPRAZOLE CAPSULE, DELAYED RELEASE ORAL 40 mg | PANTOPRAZOLE | A02BC02 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR ACID RELATED DISORDERS | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | Proton pump inhibitors | pantoprazole |
Pursina Pharmaceutical Co. | GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL | GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL | GUAIFENESIN | R05CA03 | RESPIRATORY SYSTEM | COUGH AND COLD PREPARATIONS | EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS | Expectorants | guaifenesin |
Sina Darou Laboratories | BECLEX INHALANT RESPIRATORY 50 ug/1{dose} 200 {Puff} | BECLOMETHASONE DIPROPIONATE INHALANT RESPIRATORY 50 ug/1{dose} 200 {Puff} | BECLOMETHASONE DIPROPIONATE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Shafa Pharmaceutical & Hygienic Mfg.co. | CITALOPRAM-SHAFA TABLET ORAL 20 mg | CITALOPRAM TABLET ORAL 20 mg | CITALOPRAM | N06AB04 | NERVOUS SYSTEM | PSYCHOANALEPTICS | ANTIDEPRESSANTS | Selective serotonin reuptake inhibitors | citalopram |
Loghman Pharmaceutical & Hygienic (public) | ACICLOVIR TABLET ORAL 200 mg | ACICLOVIR TABLET ORAL 200 mg | ACICLOVIR | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pars Darou | CLOTRIMAZOLE CREAM VAGINAL 1 % 50 g | CLOTRIMAZOLE CREAM VAGINAL 1 % 50 g | CLOTRIMAZOLE | G01AF02 | GENITO URINARY SYSTEM AND SEX HORMONES | GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS | ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | Imidazole derivatives | clotrimazole |
Caspian Tamin Co. | VIKADIC INJECTION PARENTERAL 10 mg/1mL 1 mL | VITAMIN K1 (PHYTOMENADIONE) INJECTION PARENTERAL 10 mg/1mL 1 mL | VITAMIN K1 (PHYTOMENADIONE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Amin Pharmaceutical Co. | GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL | GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL | GUAIFENESIN | R05CA03 | RESPIRATORY SYSTEM | COUGH AND COLD PREPARATIONS | EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS | Expectorants | guaifenesin |
Iranian Parenteral And Pharmaceutical Co. | SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.45 % 500 mL | SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.45 % 500 mL | SODIUM CHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Iran Najo | POVIDONE IODINE-NAJO SOLUTION TOPICAL 10 % 250 mL | POVIDONE IODINE SOLUTION TOPICAL 10 % 250 mL | POVIDONE IODINE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Amin Pharmaceutical Co. | RANOLAZE TABLET, EXTENDED RELEASE ORAL 500 mg | RANOLAZINE TABLET, EXTENDED RELEASE ORAL 500 mg | RANOLAZINE | null | null | null | null | null | null |
Soha Pharmaceutical Co. | PRUVIL SUSPENSION ORAL 100 mg/5mL 120 mL | IBUPROFEN SUSPENSION ORAL 100 mg/5mL 120 mL | IBUPROFEN | M01AE01 | MUSCULO-SKELETAL SYSTEM | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | Propionic acid derivatives | ibuprofen |
Shahid Ghazi Pharmaceutical Co. | HYPERSALINE INJECTION, SOLUTION PARENTERAL 5 % 50 mL | SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 5 % 50 mL | SODIUM CHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Arimed | VENIDIL CAPSULE RESPIRATORY 12 ug | FORMOTEROL FUMARATE CAPSULE RESPIRATORY 12 ug | FORMOTEROL FUMARATE | R03AC13 | RESPIRATORY SYSTEM | DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES | ADRENERGICS, INHALANTS | Selective beta-2-adrenoreceptor agonists | formoterol |
Exir Pharmaceutical Company | LOPIROX INJECTION PARENTERAL 20 mg/1mL mg | PIROXICAM INJECTION PARENTERAL 20 mg/1mL | PIROXICAM | M01AC01 | MUSCULO-SKELETAL SYSTEM | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | Oxicams | piroxicam |
Darou Pakhsh | INDOMETHACIN SUPPOSITORY RECTAL 100 mg | INDOMETHACIN SUPPOSITORY RECTAL 100 mg | INDOMETHACIN | M01AB01 | MUSCULO-SKELETAL SYSTEM | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | Acetic acid derivatives and related substances | indometacin |
Razak Labratories | MELOXICAM TABLET ORAL 15 mg | MELOXICAM TABLET ORAL 15 mg | MELOXICAM | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pars Darou | ASPIRIN TABLET, DELAYED RELEASE ORAL 81 mg | ASA (ACETYLSALICYLIC ACID) TABLET, DELAYED RELEASE ORAL 81 mg | ASA (ACETYLSALICYLIC ACID) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pursina Pharmaceutical Co. | ATENOLOL TABLET ORAL 50 mg | ATENOLOL TABLET ORAL 50 mg | ATENOLOL | C07AB03 | CARDIOVASCULAR SYSTEM | BETA BLOCKING AGENTS | BETA BLOCKING AGENTS | Beta blocking agents, selective | atenolol |
Aburaihan Pharmaceutical Co | ESTRADIOL VALERATE TABLET ORAL 2 mg | ESTRADIOL VALERATE TABLET ORAL 2 mg | ESTRADIOL VALERATE | G03CA03 | GENITO URINARY SYSTEM AND SEX HORMONES | SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM | ESTROGENS | Natural and semisynthetic estrogens, plain | estradiol |
Amin Pharmaceutical Co. | CLINDAMYCIN CAPSULE ORAL 150 mg | CLINDAMYCIN (AS HYDROCHLORIDE) CAPSULE ORAL 150 mg | CLINDAMYCIN (AS HYDROCHLORIDE) | J01FF01 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | Lincosamides | clindamycin |
Darou Pakhsh | BISOPROLOL TABLET ORAL 5 mg | BISOPROLOL FUMARATE TABLET ORAL 5 mg | BISOPROLOL FUMARATE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pharmachemie | IBUPROFEN GEL TOPICAL 5 % 50 g | IBUPROFEN GEL TOPICAL 5 % 50 g | IBUPROFEN | M02AA13 | MUSCULO-SKELETAL SYSTEM | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | Antiinflammatory preparations, non-steroids for topical use | ibuprofen |
Jaber Ebne Hayyan | PEN INJECTION, POWDER, FOR SOLUTION PARENTERAL 600000 U/300000 U/300000 U [iU] | PENICILLIN 6-3-3 INJECTION, POWDER, FOR SOLUTION PARENTERAL 600000 U/300000 U/300000 U | PENICILLIN 6-3-3 | J01RA01 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | COMBINATIONS OF ANTIBACTERIALS | Combinations of antibacterials | penicillins, combinations with other antibacterials |
Caspian Tamin Co. | IPICLOMIN INJECTION PARENTERAL 10 mg/1mL 2 mL | DICYCLOMINE HYDROCHLORIDE INJECTION PARENTERAL 10 mg/1mL 2 mL | DICYCLOMINE HYDROCHLORIDE | A03AA07 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | Synthetic anticholinergics, esters with tertiary amino group | dicycloverine |
G. Pohl-boskamp Gmbh & Co. Kg | NITROLINGUAL SPRAY SUBLINGUAL 400 ug/1{dose} 200 mL | NITROGLYCERIN SPRAY SUBLINGUAL 400 ug/1{dose} 200 {dose} | NITROGLYCERIN | C01DA02 | CARDIOVASCULAR SYSTEM | CARDIAC THERAPY | VASODILATORS USED IN CARDIAC DISEASES | Organic nitrates | glyceryl trinitrate |
Amin Pharmaceutical Co. | CIPROFECT TABLET ORAL 500 mg | CIPROFLOXACIN TABLET ORAL 500 mg | CIPROFLOXACIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Rayhaneh Pharmaceutical Co. | PREGABALIN CAPSULE ORAL 150 mg | PREGABALIN CAPSULE ORAL 150 mg | PREGABALIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Hakim Pharmaceutical Co. | CETRIKIM TABLET ORAL 10 mg | CETIRIZINE HYDROCHLORIDE TABLET ORAL 10 mg | CETIRIZINE HYDROCHLORIDE | R06AE07 | RESPIRATORY SYSTEM | ANTIHISTAMINES FOR SYSTEMIC USE | ANTIHISTAMINES FOR SYSTEMIC USE | Piperazine derivatives | cetirizine |
Cinnagen Co. | CINNAPOIETIN INJECTION PARENTERAL 2000 [iU]/0.3mL [iU] | EPOETIN INJECTION PARENTERAL 2000 [iU]/0.3mL | EPOETIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Soha Pharmaceutical Co. | METFORBET TABLET ORAL 1000 mg | METFORMIN HYDROCHLORIDE TABLET ORAL 1000 mg | METFORMIN HYDROCHLORIDE | A10BA02 | ALIMENTARY TRACT AND METABOLISM | DRUGS USED IN DIABETES | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | Biguanides | metformin |
Fresenius Kabi Austria Gmbh | PROPOFOL GENTHON INJECTION, EMULSION PARENTERAL 10 mg/1mL 20 mg | PROPOFOL INJECTION, EMULSION PARENTERAL 10 mg/1mL 20 mL | PROPOFOL | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Exir Pharmaceutical Company | LEVOFLOXACIN TABLET ORAL 750 mg | LEVOFLOXACIN TABLET ORAL 750 mg | LEVOFLOXACIN | J01MA12 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | QUINOLONE ANTIBACTERIALS | Fluoroquinolones | levofloxacin |
Darou Pakhsh | DEXTROSE INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 50 % 500 mL | DEXTROSE INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 50 % 500 mL | DEXTROSE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Alborzdarou | METOCLOPRAMIDE INJECTION PARENTERAL 5 mg/1mL 2 mg | METOCLOPRAMIDE INJECTION PARENTERAL 5 mg/1mL 2 mL | METOCLOPRAMIDE | A03FA01 | ALIMENTARY TRACT AND METABOLISM | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | PROPULSIVES | Propulsives | metoclopramide |
Amin Pharmaceutical Co. | LEVOPARKIN TABLET ORAL 100 mg/25 mg | LEVODOPA / BENSERAZIDE TABLET ORAL 100 mg/25 mg | LEVODOPA / BENSERAZIDE | N04BA02 | NERVOUS SYSTEM | ANTI-PARKINSON DRUGS | DOPAMINERGIC AGENTS | Dopa and dopa derivatives | levodopa and decarboxylase inhibitor |
Cosar Pharmaceutical | IRAPRAX POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 100 g | CEFIXIME POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 100 mL | CEFIXIME | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Aryapharmaceutical | ACETAMINOPHEN ARYA TABLET ORAL 500 mg | ACETAMINOPHEN TABLET ORAL 500 mg | ACETAMINOPHEN | N02BE01 | NERVOUS SYSTEM | ANALGESICS | OTHER ANALGESICS AND ANTIPYRETICS | Anilides | paracetamol |
Shirazserum | DEXTROSE INJECTION, SOLUTION INTRAVENOUS 5 % 500 mL | DEXTROSE INJECTION, SOLUTION INTRAVENOUS 5 % 500 mL | DEXTROSE | B05BA03 | BLOOD AND BLOOD FORMING ORGANS | BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS | I.V. SOLUTIONS | Solutions for parenteral nutrition | carbohydrates |
Pharmachemie | SILDENAFIL TABLET ORAL 100 mg | SILDENAFIL (AS CITRATE) TABLET ORAL 100 mg | SILDENAFIL (AS CITRATE) | G04BE03 | GENITO URINARY SYSTEM AND SEX HORMONES | UROLOGICALS | UROLOGICALS | Drugs used in erectile dysfunction | sildenafil |
Aburaihan Pharmaceutical Co | RHINOFEX TABLET ORAL 180 mg | FEXOFENADINE HYDROCHLORIDE TABLET ORAL 180 mg | FEXOFENADINE HYDROCHLORIDE | R06AX26 | RESPIRATORY SYSTEM | ANTIHISTAMINES FOR SYSTEMIC USE | ANTIHISTAMINES FOR SYSTEMIC USE | Other antihistamines for systemic use | fexofenadine |
Sobhan Oncology | SUNITINIB AQVIDA CAPSULE ORAL 25 mg | SUNITINIB CAPSULE ORAL 25 mg | SUNITINIB | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Chemidarou | ONDANSETRON INJECTION PARENTERAL 2 mg/1 mL 2 mL | ONDANSETRON INJECTION PARENTERAL 2 mg/1 mL 2 mL | ONDANSETRON | A04AA01 | ALIMENTARY TRACT AND METABOLISM | ANTIEMETICS AND ANTINAUSEANTS | ANTIEMETICS AND ANTINAUSEANTS | Serotonin (5HT3) antagonists | ondansetron |
Loghman Pharmaceutical & Hygienic (public) | CEFALEXIN POWDER, FOR SUSPENSION ORAL 250 mg/5 mL 100 mL | CEFALEXIN POWDER, FOR SUSPENSION ORAL 250 mg/5 mL 100 mL | CEFALEXIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Amin Pharmaceutical Co. | PRAZOSIN TABLET ORAL 1 mg | PRAZOSIN TABLET ORAL 1 mg | PRAZOSIN | C02CA01 | CARDIOVASCULAR SYSTEM | ANTIHYPERTENSIVES | ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING | Alpha-adrenoreceptor antagonists | prazosin |
Alborzdarou | ALFEN-XL TABLET, EXTENDED RELEASE ORAL 100 mg | DICLOFENAC SODIUM TABLET, EXTENDED RELEASE ORAL 100 mg | DICLOFENAC SODIUM | M01AB05 | MUSCULO-SKELETAL SYSTEM | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | Acetic acid derivatives and related substances | diclofenac |
Raha Pharmaceutical Isfahan Company | THEOPHYLLINE-G SOLUTION ORAL 50 mg/30 mg/5mL 120 mL | THEOPHYLLINE / GUAIFENESIN SOLUTION ORAL 50 mg/30 mg/5mL 120 mL | THEOPHYLLINE / GUAIFENESIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Behvazan Pharmaceutical | INDOMETHACIN-BEHVAZAN SUPPOSITORY RECTAL 100 mg | INDOMETHACIN SUPPOSITORY RECTAL 100 mg | INDOMETHACIN | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Pursina Pharmaceutical Co. | DIPHENHYDRAMINE SOLUTION ORAL 12.5 mg/5mL 60 mL | DIPHENHYDRAMINE HYDROCHLORIDE SOLUTION ORAL 12.5 mg/5mL 60 mL | DIPHENHYDRAMINE HYDROCHLORIDE | R06AA02 | RESPIRATORY SYSTEM | ANTIHISTAMINES FOR SYSTEMIC USE | ANTIHISTAMINES FOR SYSTEMIC USE | Aminoalkyl ethers | diphenhydramine |
Caspian Tamin Co. | IPACIN INJECTION PARENTERAL 250 mg/1mL 2 mL | AMIKACIN (AS SULFATE) INJECTION PARENTERAL 250 mg/1mL 2 mL | AMIKACIN (AS SULFATE) | J01GB06 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIBACTERIALS FOR SYSTEMIC USE | AMINOGLYCOSIDE ANTIBACTERIALS | Other aminoglycosides | amikacin |
Alhavi | DICYCLOMINE-ALHAVI ELIXIR ORAL 10 mg/5mL 60 mL | DICYCLOMINE HYDROCHLORIDE ELIXIR ORAL 10 mg/5mL 60 mL | DICYCLOMINE HYDROCHLORIDE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Aburaihan Pharmaceutical Co | SEVABONAT TABLET ORAL 800 mg | SEVELAMER CARBONATE TABLET ORAL 800 mg | SEVELAMER CARBONATE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Hakim Pharmaceutical Co. | OMEPRAKIM CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg | OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg | OMEPRAZOLE | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Caspian Tamin Co. | DALADIC INJECTION PARENTERAL 150 mg/1mL 2 mL | CLINDAMYCIN (AS PHOSPHATE) INJECTION PARENTERAL 150 mg/1mL 2 mL | CLINDAMYCIN (AS PHOSPHATE) | J05AB14 | ANTIINFECTIVES FOR SYSTEMIC USE | ANTIVIRALS FOR SYSTEMIC USE | DIRECT ACTING ANTIVIRALS | Nucleosides and nucleotides excl. reverse transcriptase inhibitors | valganciclovir |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.